Canadian Cardiovascular Society Cardiovascular Screening of Competitive Athletes: The Utility of the Screening Electrocardiogram to Predict Sudden Cardiac Death.


Journal

The Canadian journal of cardiology
ISSN: 1916-7075
Titre abrégé: Can J Cardiol
Pays: England
ID NLM: 8510280

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 24 06 2019
revised: 01 08 2019
accepted: 01 08 2019
entrez: 5 11 2019
pubmed: 5 11 2019
medline: 14 5 2020
Statut: ppublish

Résumé

Prevention of sudden cardiac arrest/death (SCA/D) among athletes is a universal goal, although the optimal strategy for its achievement is controversial, with the inclusion of the 12-lead electrocardiogram (ECG) at the center of the debate. The ECG exhibits superior sensitivity over history and physical examination to detect conditions associated with SCA/D. However, the identification of disease does not necessarily lead to a significant reduction in SCA/D. The "Canadian Cardiovascular Society/Canadian Heart Rhythm Society Joint Position Statement on the Cardiovascular Screening of Competitive Athletes" recommended against the routine performance of an ECG for the initial cardiovascular screening of competitive athletes. The incidence of SCA/D among athletes (<35 years of age), the risk of SCA/D during sport participation among individuals with abnormalities found on screening ECG, the efficacy of the ECG to identify conditions associated with SCA/D, and the positive predictive value of an abnormal ECG to predict SCA/D are critically examined. This review presents the evidence informing the panel's recommendation.

Identifiants

pubmed: 31679625
pii: S0828-282X(19)31170-5
doi: 10.1016/j.cjca.2019.08.023
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1557-1566

Informations de copyright

Copyright © 2019 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Auteurs

James McKinney (J)

University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: james.mckinney@ubc.ca.

Amer M Johri (AM)

Queen's University, Kingston, Ontario, Canada.

Paul Poirier (P)

Universite Laval, Quebec, Quebec, Canada.

Anne Fournier (A)

University of Montreal, Montreal, Quebec, Canada.

Jack M Goodman (JM)

University of Toronto, Toronto, Ontario, Canada.

Nathaniel Moulson (N)

University of British Columbia, Vancouver, British Columbia, Canada.

Andrew Pipe (A)

University of Ottawa, Ottawa, Ontario, Canada.

François Philippon (F)

Universite Laval, Quebec, Quebec, Canada.

Taryn Taylor (T)

Carleton Sport Medicine Clinic, Ottawa, Ontario, Canada.

Kim Connelly (K)

University of British Columbia, Vancouver, British Columbia, Canada.

Paul Dorian (P)

University of British Columbia, Vancouver, British Columbia, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH